Ropes & Gray has advised Bain Capital on the transaction. Kailera Therapeutics, a clinical-stage biopharmaceutical company specializing in obesity therapies, has announced the closing of a...
Kailera Therapeutics Raises $600 Million in Series B Financing
MapLight Therapeutics’ $372.5 Million Series D Financing
Ropes & Gray has advised Sanofi, and Cooley has advised MapLight Therapeutics on the transaction. MapLight Therapeutics, a biotechnology company focused on developing therapeutics for central...
Sanofi Invests up to $25 Million in Adagene SAFEbody Antibody Program
Ropes & Gray has advised Sanofi. Davis Polk & Wardwell and Walkers (Hong Kong) have advised Adagene Inc. Sanofi has announced a strategic investment of up...
Curevo’s $110 Million Series B Financing Round
Ropes & Gray represented Sanofi Ventures in the transaction. Curevo Vaccine (Curevo) announced raising $110 million in Series B financing. Leading the round is new investor...
Enveda’s $150 Million Series C Financing Round
Ropes & Gray represented Sanofi in the transaction. Enveda announced it has raised $150 million in a Series C financing round, led by Sanofi Ventures. The...
Atalanta Therapeutics’ $97 Million Series B Financing Round
Ropes & Gray represented Sanofi in the transaction. Atalanta Therapeutics announced it has raised $97 million in Series B financing. The financing was co-led by EQT...
SK Biopharmaceuticals’ License Agreement with Full-Life Technologies
Ropes & Gray represented SK Biopharmaceuticals on the transaction. SK Biopharmaceuticals announced it has entered into an global licensing agreement with radiotherapy company Full-Life Technologies (“Full-Life”)...
Nona Biosciences’ Global License and Option Agreement with AstraZeneca
Ropes & Gray advised Nona Biosciences on the deal. Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal...